Semaglutide: STEP Trials STEP 1 Trial People took 2.4 mg of semaglutide each week and made lifestyle changes
Graham Lipkin, a Consultant Nephrologist at Queen Elizabeth Hospital Birmingham, highlights this risk: "Some of the side effects of GLP-1 medicines include dehydration, which can result in acute kidney injury (AKI)
So, at least in these doses (more than twice the Institute of Medicine recommendation), there appears to be no additional health benefit
Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap n collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction
Semaglutide clinical trials have shown a 15-18% body fat decrease in obese or overweight patients